(Date:11/6/2009)...UMBUS, Ohio, Nov. 6 Authentidate Holding Corp. (N...lth Information Exchange and workflow management s...nscrybe® Healthcare to be easily integrated w...tion systems, Definitive Homecare Solutions, CPR+(...CPR+ Integrated Solutions Provider program, a prog...
(Date:11/6/2009)...lthcare Trust of America, Inc. (the "REIT"), a sel...t, announced the execution of a Purchase and Sale ...ffice building located in Englewood, Colorado for ...edical Center is located within the Englewood City...nt district. Hampden Place is located near the Swe...
(Date:11/6/2009)...ernational, a leading children,s development organ...rld, has been asked to deliver eight presentations...ng American Public Health Association,s (APHA) Ann...sylvania on November 7-11, 2009. ,, The American ...gether to address current and emerging health scie...
(Date:11/6/2009)...e need to exert more pressure from the lungs, rese...News) -- Hormonal fluctuations make it harder for .... , Many professional singers have difficulty sing...er this was because of hormones or other causes, s..., In this study, researchers followed a profession...
(Date:11/6/2009)...ailable, with 8 million more due next week, , ...the total doses of H1N1 swine flu vaccine availabl...illion more than a week ago -- most Americans who ...S. health officials acknowledged Friday. , In fact...who tried to get vaccinated couldn,t, according to...
Breaking Medicine News(10 mins):Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 2Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 4Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 3Health News:Plan's Expertise Highlighted at Premier Health Forum 2Health News:Most Who Want Swine Flu Shot Can't Get It 2Health News:Most Who Want Swine Flu Shot Can't Get It 3...ony Ohotto, a physician,with Signature Hospice, ha...ttoo. "Limited life expectancy is no reason not to...e wrote the order as a health clearance, a,stateme... emotional decline in their young patient with a n...
...Long-Time Twin Cities Health Care ...rk G. Mishek, a Minnesota native,with extensive ex... Monday,as President and CEO of Hazelden, the nati...o: http://www.newscom.com/cgi-bin/prnh/20080825/A...
...ecting the expanding,scope of chronic disease care...environmental factors on health care systems and p...blisher Mary Ann Liebert Inc. have renamed,the pee... (Volume 11, Number 4). With the new name comes a,...
...n with certain genotype more affected, study finds...reast-feeding moms who take medicines containing c...eir infant, new Canadian research suggests. , The ... -- possibly harming the infant,s central nervous ...
...ases the risk of developing cancers of the respira...ysis, which the authors say is the first prospecti...rs in the October 1, 2008 issue of CANCER, a pee...rning incensewhich is made of plant materials mixe...
...enefit Group, LLC announces iCan Insurance, LLC (&...w offering major medical health plans from Avalon ...aton, FL (PRWEB) August 24, 2008 -- iCan Benefit G...re, Inc. http://www.icanbenefit.com/majorMedical/...
Other Medicine News:Health News:Signature Hospice Team Grants Patient's Unusual Wish 2Health News:Mark G. Mishek Is New President and CEO of Hazelden 2Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 2Health News:Taking Codeine While Breast-Feeding May Harm Infant 3Health News:Burning incense increases risk of respiratory tract cancers 2Health News:iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products 2(Date:11/5/2009)... EATONTOWN, N.J., Nov. 5 ... emerging field of biologic products for regenerat...the third quarter ended September 30, 2009. ,, ...n the release of our three new biologic products ...hnology and Plexur M® Innovative Grafting," s...
(Date:11/5/2009)... AURORA, Ontario, Nov. 5 ...XBPF) announced today that its Phase II trial of T...o-genital warts (AGW) has completed patient enroll...o enter the trial. ,, The double-blind and plac...ple centers in Germany and Sweden. Patients parti...
(Date:11/5/2009)... NEW YORK, Nov. 5 DOTmed, the lead...leader in online medical equipment auctions, today...-Atlantic Group Network of Shared Services (MAGNET...cal equipment and idle assets. MAGNET was created...provider members in the niche market of capital eq...
Breaking Medicine Technology:Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6MAGNET Selects DOTmed.com to Assist Members in Sale of Used Medical Equipment and Idle Assets 2Tevas Patient First Initiative Highlights Struggle Against High Health Care Costs Reminds Lawmakers of Reform Goals 54977 1Tevas Patient First Initiative Highlights Struggle Against High Health Care Costs Reminds Lawmakers of Reform Goals 54977 2Tevas Patient First Initiative Highlights Struggle Against High Health Care Costs Reminds Lawmakers of Reform Goals 54977 3American Red Cross Provides Safety Tips for Rip Tides Caused by Hurricane Bill 54972 1American Red Cross Provides Safety Tips for Rip Tides Caused by Hurricane Bill 54972 2Night home hemodialysis shown to be as good as transplant in treating kidney failure 54967 1Night home hemodialysis shown to be as good as transplant in treating kidney failure 54967 2...ging Results for a Potential New Front-Line Treatm...AMBRIDGE, Mass., June 2 Genzyme Corp.,(Nasdaq: G...-enrolled,pivotal, phase 2 study examining the saf...s a single agent in previously untreated, older ad... who are unlikely to benefit,from conventional "7+...
...esponse Trends Suggest Improved Efficacy with High... - Dose Escalation Ongoing -, SAN ...sdaq: MDVN ) today announced that data from an on...vel androgen receptor antagonist,MDV3100, showed e...ining,serum levels of prostate specific antigen (P...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 4Liquichek Autoimmune Controls - Anti-Sm
VARIANTnbs Newborn Hemoglobin Screening System
...ring GmbH, the leading developer of laser diagnost...roduction of the Heidelberg Retina Tomograph 3 (HR...uct for the assessment, diagnosis and management o...ses laser technology to produce a topographical im...
Visante OCT Anterior Segment Imaging and Biometry
Medicine Products: